Organogenesis Holdings INC. (ORGO) — 8-K Filings

All 8-K filings from Organogenesis Holdings INC.. Browse 9 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (9)

Organogenesis Holdings Inc. Files 8-K — Dec 29, 2025 Risk: low
Organogenesis Holdings Inc. filed an 8-K on December 29, 2025, reporting an entry into a material definitive agreement and financial statements/exhibits. The fi
Organogenesis Holdings Inc. Files 8-K — Sep 25, 2025 Risk: low
Organogenesis Holdings Inc. filed an 8-K on September 25, 2025, reporting on various events. The filing includes information related to Regulation FD disclosure
Organogenesis Holdings Inc. Announces Board and Executive Changes — Jun 24, 2025 Risk: medium
Organogenesis Holdings Inc. announced on June 23, 2025, changes related to its board of directors and executive compensation. The filing indicates a departure o
8-K Filing — Mar 27, 2025
Organogenesis Holdings Inc. Files 8-K for Material Agreement — Dec 2, 2024 Risk: medium
Organogenesis Holdings Inc. entered into a Material Definitive Agreement on November 27, 2024. The filing also includes financial statements and exhibits. The c
Organogenesis Holdings Inc. Files 8-K for Material Definitive Agreement — Nov 22, 2024 Risk: medium
Organogenesis Holdings Inc. announced on November 18, 2024, that it entered into a Material Definitive Agreement. The company, formerly known as Avista Healthca
Organogenesis Holdings Inc. Files 8-K with Material Agreements and Officer Changes — Nov 13, 2024 Risk: medium
Organogenesis Holdings Inc. announced on November 12, 2024, that it entered into a material definitive agreement. The company also reported on triggering events
Organogenesis Names New CEO and CFO — Jun 21, 2024 Risk: medium
Organogenesis Holdings Inc. announced on June 20, 2024, that its Board of Directors has appointed Dr. Marc H. Miller as Chief Executive Officer, effective immed
Organogenesis Sells Trauma Business to Acellixx — Apr 3, 2024 Risk: medium
Organogenesis Holdings Inc. announced on April 3, 2024, that it has entered into a definitive agreement to sell its Trauma business to Acellixx, Inc. for an und

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX